| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Revenue | $1.60B | +23.4% |
| Cost of Revenue | $1.07B | +23.6% |
| Gross Profit | $531.3M | +22.9% |
| R&D Expense | $56.2M | +20.7% |
| SG&A Expense | $116.1M | +19.4% |
| Operating Income | $246.7M | +25.3% |
| Interest Expense | $8.9M | +9.5% |
| Pre-tax Income | $233.8M | +24.1% |
| Income Tax | $28.5M |
| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $200.4M | +41.1% |
| Inventory | $350.6M | +25.3% |
| Current Assets | $797.7M | +10.1% |
| Total Assets | $1.62B | +6.8% |
| Current Liabilities | $258.9M | +12.6% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $496.9M | -20.1% |
| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $187.1M | +186.6% |
| Capital Expenditures | $43.7M | -20.3% |
| Investing Cash Flow | -$44.7M | +58.1% |
| Financing Cash Flow | -$179.1M | -643.3% |
| Free Cash Flow | $143.4M | +1273.0% |
| +16.0% |
| Net Income | $205.3M | +25.3% |
| EPS (Basic) | $4.86 | +24.6% |
| EPS (Diluted) | $4.84 | +25.1% |
| Stockholders' Equity |
| $1.12B |
| +25.4% |